-$93,000
Est. value of NVO Stock Transactions by US Politicians Over the Past 2 Years.

Sign up to access historical data

Sign up

Trades by US Politicians

Politician Filing Date Type Size
Michael McCaul
Oct 31, 2024Buy$15K - $50K
Michael McCaul
May 29, 2024Buy$15K - $50K
Michael McCaul
May 28, 2024Buy$15K - $50K
Michael McCaul
May 6, 2024Buy$15K - $50K
Michael McCaul
Republican
Apr 24, 2024Buy$50K - $100K
Michael McCaul
Republican
Apr 24, 2024Buy$50K - $100K
Michael McCaul
Republican
Apr 23, 2024Buy$50K - $100K
Michael McCaul
Republican
Apr 23, 2024Buy$100K - $250K
Rohit Khanna
Democrat
Feb 9, 2024Sell$50K - $100K
Thomas Tuberville
Republican
Jan 19, 2024Sell$15K - $50K
John James
Nov 10, 2023Buy$1K - $15K
Rohit Khanna
Democrat
Sep 8, 2023Buy$1K - $15K
Daniel S. Goldman
Democrat
Jul 12, 2023Sell$100K - $250K
Daniel S. Goldman
Democrat
Jul 10, 2023Sell$250K - $500K
Rohit Khanna
Democrat
Mar 10, 2023Sell$1K - $15K
Rohit Khanna
Democrat
Feb 10, 2023Buy$15K - $50K
Rohit Khanna
Democrat
Dec 5, 2022Sell$1K - $15K

Who is the latest politician to buy or sell Novo Nordisk shares?

Michael McCaul purchased Novo Nordisk shares most recently on October 31, 2024.

Which politician has bought the most NVO stock in the last two years?

Michael McCaul has bought the most NVO stock in the last 2 years, with an estimated value of $530,000.

Which politician has sold the most NVO stock over the last two years?

Daniel S. Goldman has sold the most NVO stock in the last 2 years, with an estimated value of $550,000.

What is the total value of politicians trading NVO stock in the last 2 years?

The net value of trades by US politicians for Novo Nordisk in the last 2 years is negative, amounting to -$93,000. This suggests that US politicians do not believe in the success of the company for various reasons.

How do insider transactions over the last 2 years reflect on Novo Nordisk's market confidence?

Over the last 2 years, insider transactions for Novo Nordisk have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.

Why should individual investors pay attention to the stock transactions of US politicians?

Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.